CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
ECOA RESOURCES
-
Empower your study participants with IQVIA eCOA’s tailored user experiences, flexible event triggers for clinicians, comprehensive training resources, and 24/7 support for seamless study management.
-
If you're ready to streamline your clinical trials and deliver better outcomes for all stakeholders, explore how the Suvoda Platform can transform your trial experience today.
-
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
ECONSENT RESOURCES
-
Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.
EPRO RESOURCES
-
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Discover effective strategies and solutions to overcome challenges in oncology studies and how to optimize trial design, patient recruitment, data management, and regulatory compliance.
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.